Factors influencing the effect of age on prognosis in breast cancer: population based study

doi:10.1136/bmj.320.7233.474

BMJ 2000;320:474-479 ( 19 February )

Papers

Editorial by Dixon and Hortobagyi

Niels Kroman, senior registrar, ^a Maj-Britt Jensen, statistician, ^b Jan Wohlfahrt, senior statistician, ^a Henning T Mouridsen, consultant oncologist, ^b Per Kragh Andersen, professor, ^c Mads Melbye, professor. ^a

^a Department of Epidemiology Research, Danish Epidemiology Science Centre, Statens Serum Institut, DK 2300 Copenhagen, Denmark, ^b Danish Breast Cancer Cooperative Group, Rigshospitalet, DK 2100 Copenhagen, Denmark, ^c Department of Biostatistics, University of Copenhagen, DK 2200 Copenhagen, Denmark

Correspondence to: M Melbye mme{at}ssi.dk

Objective: To investigate whether young age at diagnosisis a negative prognostic factor in primary breast cancer and howstage of disease at diagnosis and treatment influences such anassociation.
Design: Retrospective cohort study based on a populationbased database of patients with breast cancer containing detailedinformation on tumour characteristics, treatment regimens, andsurvival.
Setting: Denmark.
Subjects: 10 356 women with primary breast cancer whowere less than 50 years old atdiagnosis.
Main outcome measures: Relative risk of dying within the first 10years after diagnosis according to age at diagnosis after adjustmentfor known prognostic factors and expectedmortality.
Results: Overall, young women with low risk diseasewho did not receive adjuvant treatment had a significantly increasedrisk of dying; risk increased with decreasing age at diagnosis(adjusted relative risk: 45-49 years (reference): 1; 40-44 years:1.12 (95% confidence interval 0.89 to 1.40); 35-39 years: 1.40(1.10 to 1.78); <35 years: 2.18 (1.64 to 2.89). However, no similartrend was seen in patients who received adjuvant cytotoxic treatment.The increased risk in younger women who did not receive adjuvanttreatment compared with those who did remained when women weregrouped according to presence of node negative disease and bytumoursize.
Conclusion: The negative prognostic effect of young ageis almost exclusively seen in women diagnosed with low risk diseasewho did not receive adjuvant cytotoxic treatment. These resultssuggest that young women with breast cancer, on the basis of agealone, should be regarded as high risk patients and be given adjuvantcytotoxictreatment.

© BMJ 2000

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Articles

Optimum treatment for young women with breast cancer needs to be determined: Richard Sainsbury and Bob Haward
BMJ 2000 321: 53. [Extract] [Full Text]

Chemotherapy may benefit young, low risk breast cancer patients
BMJ 2000 320: 0. [Full Text]

Treating young patients with breast cancer: J M Dixon and G Hortobagyi
BMJ 2000 320: 457-458. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

Ejlertsen, B., Jensen, M.-B., Rank, F., Rasmussen, B. B., Christiansen, P., Kroman, N., Kvistgaard, M. E., Overgaard, M., Toftdahl, D. B., Mouridsen, H. T., on behalf of the Danish Breast Cancer Cooperative, (2009). Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer. JNCI J Natl Cancer Inst 101: 729-735 [Abstract] [Full text]
Johnson, N., Dickson-Swift, V. (2008). `It usually happens in older women': Young women's perceptions about breast cancer. Health Education Journal 67: 243-257 [Abstract]
Macrae, W. A. (2008). Chronic post-surgical pain: 10 years on. Br J Anaesth 101: 77-86 [Abstract] [Full text]
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thurlimann, B., Senn, H. -J., Panel Members, (2007). Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18: 1133-1144 [Abstract] [Full text]
Ahn, S. H., Son, B. H., Kim, S. W., Kim, S. I., Jeong, J., Ko, S.-S., Han, W. (2007). Poor Outcome of Hormone Receptor-Positive Breast Cancer at Very Young Age Is Due to Tamoxifen Resistance: Nationwide Survival Data in Korea--A Report From the Korean Breast Cancer Society. JCO 25: 2360-2368 [Abstract] [Full text]
Paskett, E. D., Naughton, M. J., McCoy, T. P., Case, L. D., Abbott, J. M. (2007). The Epidemiology of Arm and Hand Swelling in Premenopausal Breast Cancer Survivors. Cancer Epidemiol. Biomarkers Prev. 16: 775-782 [Abstract] [Full text]
Aebi, S, Castiglione, M (2006). The enigma of young age.. Ann Oncol 17: 1475-1477 [Full text]
Colleoni, M, Rotmensz, N, Peruzzotti, G, Maisonneuve, P, Orlando, L, Ghisini, R, Viale, G, Pruneri, G, Veronesi, P, Luini, A, Intra, M, Cardillo, A, Torrisi, R, Rocca, A, Goldhirsch, A (2006). Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol 17: 1497-1503 [Abstract] [Full text]
Jacobi, C. E., Nagelkerke, N. J.D., van Houwelingen, J. C., de Bock, G. H. (2006). Breast Cancer Screening, Outside the Population-Screening Program, of Women from Breast Cancer Families without Proven BRCA1/BRCA2 Mutations: a Simulation Study.. Cancer Epidemiol. Biomarkers Prev. 15: 429-436 [Abstract] [Full text]
Duffy, C. M., Allen, S. M., Clark, M. A. (2005). Discussions Regarding Reproductive Health for Young Women With Breast Cancer Undergoing Chemotherapy. JCO 23: 766-773 [Abstract] [Full text]
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thurlimann, B., Senn, H.-J. (2003). Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer. JCO 21: 3357-3365 [Abstract] [Full text]
Goldhirsch, A., Colleoni, M., Domenighetti, G., Gelber, R. D. (2003). Systemic treatments for women with breast cancer: outcome with relation to screening for the disease. Ann Oncol 14: 1212-1214 [Abstract] [Full text]
Powell, B. L., Piersma, D., Kevenaar, M. E., van Staveren, I. L., Themmen, A. P. N., Iacopetta, B. J., Berns, E. M. J. J. (2003). Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset. J. Clin. Endocrinol. Metab. 88: 1653-1657 [Abstract] [Full text]
Hjerl, K., Andersen, E. W., Keiding, N., Mouridsen, H. T., Mortensen, P. B., Jorgensen, T. (2003). Depression as a Prognostic Factor for Breast Cancer Mortality. Psychosomatics 44: 24-30 [Abstract] [Full text]
Arriagada, R., Le, M. G., Contesso, G., Guinebretiere, J. M., Rochard, F., Spielmann, M. (2002). Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 13: 1404-1413 [Abstract] [Full text]
Vicini, F. A., Recht, A. (2002). Age at Diagnosis and Outcome for Women With Ductal Carcinoma-In-Situ of the Breast: A Critical Review of the Literature. JCO 20: 2736-2744 [Abstract] [Full text]
Colleoni, M., Rotmensz, N., Robertson, C., Orlando, L., Viale, G., Renne, G., Luini, A., Veronesi, P., Intra, M., Orecchia, R., Catalano, G., Galimberti, V., Nole, F., Martinelli, G., Goldhirsch, A. (2002). Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13: 273-279 [Abstract] [Full text]
Goldhirsch, A., Gelber, R. D., Yothers, G., Gray, R. J., Green, S., Bryant, J., Gelber, S., Castiglione-Gertsch, M., Coates, A. S. (2001). Adjuvant Therapy for Very Young Women With Breast Cancer: Need for Tailored Treatments. J Natl Cancer Inst Monogr 2001: 44-51 [Abstract] [Full text]
van der Hage, J. A., van de Velde, C. J.H., Julien, J.-P., Tubiana-Hulin, M., Vandervelden, C., Duchateau, L. (2001). Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902. JCO 19: 4224-4237 [Abstract] [Full text]
Voogd, A. C., Nielsen, M., Peterse, J. L., Blichert-Toft, M., Bartelink, H., Overgaard, M., van Tienhoven, G., Andersen, K. W., Sylvester, R. J., van Dongen, J. A. (2001). Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials. JCO 19: 1688-1697 [Abstract] [Full text]
Sainsbury, R., Haward, B. (2000). Optimum treatment for young women with breast cancer needs to be determined. BMJ 321: 53-53 [Full text]
(2000). Age and Breast Cancer Prognosis. JWatch General 2000: 3-3 [Full text]
Dixon, J M, Hortobagyi, G (2000). Treating young patients with breast cancer. BMJ 320: 457-458 [Full text]